Cva Family Office, LLC Bristol Myers Squibb CO Transaction History

Cva Family Office, LLC

$753 Million
Q3 2025

A detailed history of Cva Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cva Family Office, LLC holds 8,959 shares of BMY stock, worth $419,370. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,959

Previous 8,736 2.55%

Holding current value

$419,370

Previous $404,000 -0.0%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$43.31 - $48.98 $9,658 - $10,922	223 Added 2.55%	8,959 $404,000
Q2 2025 Jul 31, 2025	SELL	$44.12 - $59.6 $32,339 - $43,686	-733 Reduced 7.74%	8,736 $404,000
Q1 2025 Apr 16, 2025	BUY	$53.9 - $63.11 $3,234 - $3,786	60 Added 0.64%	9,469 $577,000
Q4 2024 Jan 07, 2025	BUY	$51.92 - $59.94 $35,565 - $41,058	685 Added 7.85%	9,409 $532,000
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $28,991 - $37,829	731 Added 9.15%	8,724 $451,000

Q2 2024 Jul 09, 2024	BUY	$40.25 - $52.99 $49,467 - $65,124	1,229 Added 18.17%	7,993 $331,000
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $178,197 - $202,041	3,714 Added 121.77%	6,764 $366,000
Q4 2023 Jan 16, 2024	SELL	$48.48 - $57.85 $24,579 - $29,329	-507 Reduced 14.25%	3,050 $156,000
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $25,761 - $28,804	-445 Reduced 11.12%	3,557 $206,000
Q2 2023 Jul 10, 2023	BUY	$63.71 - $70.74 $2,866 - $3,183	45 Added 1.14%	4,002 $255,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $30,555 - $34,656	-465 Reduced 10.52%	3,957 $274,000
Q4 2022 Feb 21, 2023	SELL	$68.48 - $81.09 $21,023 - $24,894	-307 Reduced 6.49%	4,422 $318,000
Q3 2022 Nov 22, 2022	SELL	$0.13 - $76.84 $54 - $32,426	-422 Reduced 8.19%	4,729 $336,000
Q2 2022 Jul 11, 2022	BUY	$72.62 - $79.98 $18,300 - $20,154	252 Added 5.14%	5,151 $397,000
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $46,294 - $55,511	753 Added 18.16%	4,899 $358,000
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $125,655 - $146,484	2,343 Added 129.95%	4,146 $258,000
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $134,730 - $157,818	-2,277 Reduced 55.81%	1,803 $109,000
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $57,390 - $62,498	927 Added 29.4%	4,080 $273,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $13,232 - $14,883	223 Added 7.61%	3,153 $199,000
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $65,072 - $73,739	1,127 Added 62.51%	2,930 $181,000
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $40,947 - $45,375	713 Added 65.41%	1,803 $109,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $32,343 - $37,813	590 Added 118.0%	1,090 $64,000
Q1 2020 May 28, 2020	BUY	$46.4 - $67.43 $23,200 - $33,715	500 New	500 $28,000

Others Institutions Holding BMY

# of Institutions

2,681

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Bristol Myers Squibb CO Transaction History